Chami Nathalie, Wang Zhe, Svenstrup Victor, Obrero Virginia Diez, Hemerich Daiane, Huang Yi, Dashti Hesam, Manitta Eleonora, Preuss Michael H, North Kari E, Holm Louise Aas, Fonvig Cilius E, Holm Jens-Christian, Hansen Torben, Scheele Camilla, Rauch Alexander, Smit Roelof A J, Claussnitzer Melina, Loos Ruth J F
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Med. 2025 Sep 12. doi: 10.1038/s41591-025-03931-0.
Obesity is a heterogeneous condition not adequately captured by a single adiposity trait. We conducted a multi-trait genome-wide association analysis using individual-level data from 452,768 UK Biobank participants to study obesity in relation to cardiometabolic health. We defined continuous 'uncoupling phenotypes', ranging from high adiposity with healthy cardiometabolic profiles to low adiposity with unhealthy ones. We identified 266 variants across 205 genomic loci where adiposity-increasing alleles were simultaneously associated with lower cardiometabolic risk. A genetic risk score (GRS) aggregating these variants was associated with a lower risk of cardiometabolic disorders, including dyslipidemia and ischemic heart disease, despite higher obesity risk; unlike an adiposity score based on body fat percentage-associated variants (GRS). The 266 variants formed eight genetic subtypes of obesity, each with distinct risk profiles and pathway signatures. Proteomic analyses revealed signatures separating adiposity- and health-driven effects. Our findings reveal new mechanisms that uncouple obesity from cardiometabolic comorbidities and lay a foundation for genetically informed subtyping of obesity to support precision medicine.
肥胖是一种异质性疾病,单一的肥胖特征无法充分体现。我们利用来自452768名英国生物银行参与者的个体水平数据进行了多特征全基因组关联分析,以研究肥胖与心脏代谢健康的关系。我们定义了连续的“解耦表型”,范围从具有健康心脏代谢特征的高肥胖到具有不健康特征的低肥胖。我们在205个基因组位点上鉴定出266个变异,其中增加肥胖的等位基因同时与较低的心脏代谢风险相关。尽管肥胖风险较高,但汇总这些变异的遗传风险评分(GRS)与心脏代谢紊乱(包括血脂异常和缺血性心脏病)的较低风险相关;这与基于体脂百分比相关变异的肥胖评分(GRS)不同。这266个变异形成了八种肥胖遗传亚型,每种亚型都有独特的风险特征和通路特征。蛋白质组学分析揭示了区分肥胖驱动效应和健康驱动效应的特征。我们的研究结果揭示了将肥胖与心脏代谢合并症解耦的新机制,并为基于基因的肥胖亚型分类奠定了基础,以支持精准医学。